Voya Investment Management LLC Decreases Stock Holdings in Molina Healthcare, Inc $MOH

Voya Investment Management LLC reduced its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 52.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 12,857 shares of the company’s stock after selling 14,357 shares during the quarter. Voya Investment Management LLC’s holdings in Molina Healthcare were worth $2,460,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of MOH. Whalen Wealth Management Inc. acquired a new position in shares of Molina Healthcare in the second quarter valued at approximately $1,597,000. Arrowstreet Capital Limited Partnership grew its stake in Molina Healthcare by 71.5% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 80,559 shares of the company’s stock worth $23,999,000 after acquiring an additional 33,587 shares during the period. Invesco Ltd. raised its holdings in Molina Healthcare by 25.9% in the 2nd quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock valued at $477,109,000 after acquiring an additional 329,759 shares during the last quarter. Machina Capital S.A.S. acquired a new position in Molina Healthcare in the 2nd quarter valued at $2,126,000. Finally, Strs Ohio purchased a new position in shares of Molina Healthcare during the 2nd quarter worth $1,864,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MOH has been the subject of several analyst reports. Wells Fargo & Company dropped their target price on Molina Healthcare from $231.00 to $165.00 and set an “overweight” rating for the company in a research note on Wednesday, November 12th. Deutsche Bank Aktiengesellschaft set a $165.00 price objective on shares of Molina Healthcare in a research note on Friday, October 24th. Sanford C. Bernstein cut their price objective on shares of Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a report on Friday, September 5th. Morgan Stanley set a $158.00 target price on shares of Molina Healthcare in a research report on Friday, October 24th. Finally, The Goldman Sachs Group dropped their price target on shares of Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating for the company in a research report on Friday, October 24th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Molina Healthcare currently has an average rating of “Hold” and a consensus price target of $196.33.

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the company’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $143.02, for a total transaction of $51,058.14. Following the completion of the sale, the director directly owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Up 0.8%

Shares of NYSE:MOH opened at $164.76 on Friday. The stock has a 50-day simple moving average of $155.38 and a 200-day simple moving average of $186.28. The stock has a market capitalization of $8.93 billion, a P/E ratio of 10.20 and a beta of 0.52. Molina Healthcare, Inc has a 1 year low of $133.40 and a 1 year high of $359.97. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.68 and a current ratio of 1.68.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The business had revenue of $11.48 billion for the quarter, compared to analyst estimates of $10.99 billion. During the same period last year, the firm earned $6.01 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Equities analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.